{
  "id": "map_1679",
  "title": "Enfermedad de Peque√±os\\NVasos Cerebrales (CSVD)",
  "specialty": "Estudios Pivotales",
  "tag": "üìã Gu√≠a Cl√≠nica",
  "node_count": 516,
  "root": {
    "text": "Enfermedad de Peque√±os\\NVasos Cerebrales (CSVD)",
    "children": [
      {
        "text": "‚û§ Definici√≥n",
        "children": [
          {
            "text": "‚Æï Patolog√≠a frecuente en neurolog√≠a",
            "children": []
          },
          {
            "text": "‚Æï ‚Üë Riesgo de:",
            "children": [
              {
                "text": "‚úîÔ∏è Accidente cerebrovascular (ACV) isqu√©mico y hemorr√°gico",
                "children": []
              },
              {
                "text": "‚úîÔ∏è Infartos silentes",
                "children": []
              },
              {
                "text": "‚úîÔ∏è Deterioro cognitivo y demencia",
                "children": []
              }
            ]
          },
          {
            "text": "‚Æï Caracter√≠sticas radiogr√°ficas definidas",
            "children": []
          },
          {
            "text": "‚Æï Variabilidad en manifestaciones cl√≠nicas",
            "children": []
          },
          {
            "text": "‚Æï ‚Üë Prevalencia con la edad",
            "children": []
          },
          {
            "text": "‚Æï Pocas terapias espec√≠ficas",
            "children": []
          }
        ]
      },
      {
        "text": "EPIDEMIOLOG√çA &\\NFACTORES DE RIESGO",
        "children": [
          {
            "text": "‚û§ Impacto\\Nen la salud",
            "children": [
              {
                "text": "‚Æï 22% de los ACV isqu√©micos son por CSVD",
                "children": []
              },
              {
                "text": "‚Æï ‚Üë Riesgo de recurrencia de ACV",
                "children": []
              },
              {
                "text": "‚Æï Infartos cerebrales silentes\\N(CSVD encubierta)",
                "children": [
                  {
                    "text": "‚úîÔ∏è Prevalencia: 10-20% en adultos",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è ‚Üë Riesgo de ACV y mortalidad",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï Mayor√≠a de hemorragias intracerebrales\\N(HIC)",
                "children": [
                  {
                    "text": "‚úîÔ∏è Arteriosclerosis (hipertensiva)",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Angiopat√≠a amiloide cerebral (CAA)",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï CSVD contribuye a deterioro cognitivo y demencia",
                "children": []
              }
            ]
          },
          {
            "text": "‚û§ Factores de riesgo\\Nno modificables",
            "children": [
              {
                "text": "‚Æï\\\\/ Edad: \\NFactor m√°s relevante\\\\/",
                "children": [
                  {
                    "text": "‚úîÔ∏è ~100% en >90 a√±os",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è 36% en 80-90 a√±os con microhemorragias",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï Sexo: Hombres > Mujeres\\Nen:",
                "children": [
                  {
                    "text": "‚úîÔ∏è CSVD moderada-severa",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Presentaci√≥n con ACV agudo",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï Raza/etnia: Diferencias en\\Nimpacto y comorbilidades",
                "children": [
                  {
                    "text": "‚úîÔ∏è Negros e hispanos: Mayor carga global de CSVD",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è ERC asociada a m√°s espacios perivasculares en negros",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï Factores sociodemogr√°ficos",
                "children": [
                  {
                    "text": "‚úîÔ∏è Educaci√≥n infantil baja ‚Üí ‚Üë CSVD, independiente de FR vasculares",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "‚û§ Factores de\\Nriesgo modificables",
            "children": [
              {
                "text": "‚Æï Hipertensi√≥n (HTA)",
                "children": []
              },
              {
                "text": "‚Æï Apnea obstructiva del sue√±o (AOS)",
                "children": []
              },
              {
                "text": "‚Æï Diabetes mellitus (DM)",
                "children": []
              },
              {
                "text": "‚Æï Hiperlipidemia",
                "children": []
              },
              {
                "text": "‚Æï Tabaquismo",
                "children": []
              },
              {
                "text": "‚Æï Enfermedad renal cr√≥nica\\N(ERC)",
                "children": [
                  {
                    "text": "‚úîÔ∏è ‚Üë Microhemorragias cerebrales",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è ‚Üë Hiperintensidades de sustancia blanca",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è ‚Üë Infartos silentes",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï Relaci√≥n compleja: ERC ‚Üî HTA ‚Üî Deterioro cognitivo ‚Üî CSVD",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "HALLAZGOS\\NPATOL√ìGICOS",
        "children": [
          {
            "text": "‚û§ Definici√≥n",
            "children": [
              {
                "text": "‚Æï Afecta arterias peque√±as, arteriolas, v√©nulas y capilares cerebrales",
                "children": []
              },
              {
                "text": "‚Æï Cambios cr√≥nicos y progresivos en sustancia gris y blanca",
                "children": []
              },
              {
                "text": "‚Æï Relaci√≥n con hallazgos cl√≠nicos y radiogr√°ficos",
                "children": []
              }
            ]
          },
          {
            "text": "‚û§ Historia y\\Nestudios clave",
            "children": [
              {
                "text": "‚Æï C. Miller Fisher\\N(1965)",
                "children": [
                  {
                    "text": "‚úîÔ∏è 114 autopsias con infartos lacunares",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Lacunas: 1-4 mm (solo 17% >10 mm)",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Caracter√≠sticas\\Nmicrosc√≥picas:",
                    "children": [
                      {
                        "text": "‚ûû Cavidad irregular con tejido conectivo fino",
                        "children": []
                      },
                      {
                        "text": "‚ûû Macr√≥fagos grasos ‚Üí Disminuyen con edad de la lesi√≥n",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "‚û§ Subtipos etiopatog√©nicos\\Nde CSVD",
            "children": [
              {
                "text": "‚Æï\\\\/ Forma cl√°sica\\N(HTA, edad, FR vasculares)\\\\/",
                "children": [
                  {
                    "text": "‚úîÔ∏è ‚Üì C√©lulas musculares lisas en t√∫nica media",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Lipohialinosis",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Microateromas",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Desorganizaci√≥n arterial segmentaria",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï Angiopat√≠a amiloide cerebral\\N(CAA)",
                "children": [
                  {
                    "text": "‚úîÔ∏è Dep√≥sito de Œ≤-amiloide en paredes arteriales",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Afectaci√≥n predominante en leptomeninges",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è ‚Üì Integridad vascular ‚Üí Fragmentaci√≥n y ruptura",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "‚û§ Hip√≥tesis\\Nfisiopatol√≥gica actual",
            "children": [
              {
                "text": "‚Æï CSVD = Trastorno din√°mico\\Ny global del cerebro",
                "children": [
                  {
                    "text": "‚úîÔ∏è Disfunci√≥n endotelial",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Alteraciones en unidad neurovascular",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Potenciales dianas terap√©uticas en estudio",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "Neuroimagen en CSVD",
        "children": [
          {
            "text": "‚û§ Terminolog√≠a\\Nvariable",
            "children": [
              {
                "text": "‚Æï Leucoaraiosis",
                "children": []
              },
              {
                "text": "‚Æï Enfermedad de la sustancia blanca",
                "children": []
              },
              {
                "text": "‚Æï Leucoencefalopat√≠a",
                "children": []
              },
              {
                "text": "‚Æï Hiperintensidades de sustancia blanca",
                "children": []
              }
            ]
          },
          {
            "text": "‚û§ Estandarizaci√≥n\\N(2013, STRIVE)",
            "children": [
              {
                "text": "‚Æï Grupo multidisciplinario ‚Üí Necesidad de terminolog√≠a consistente",
                "children": []
              },
              {
                "text": "‚Æï 6 Fenotipos\\Nradiogr√°ficos de CSVD",
                "children": [
                  {
                    "text": "1Ô∏è‚É£ Infarto subcortical reciente",
                    "children": []
                  },
                  {
                    "text": "2Ô∏è‚É£ Hiperintensidades de sustancia blanca",
                    "children": []
                  },
                  {
                    "text": "3Ô∏è‚É£ Lacuna de origen vascular",
                    "children": []
                  },
                  {
                    "text": "4Ô∏è‚É£ Espacios perivasculares ensanchados",
                    "children": []
                  },
                  {
                    "text": "5Ô∏è‚É£ Microhemorragias cerebrales",
                    "children": []
                  },
                  {
                    "text": "6Ô∏è‚É£ Atrofia cerebral",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "Fenotipos Radiogr√°ficos",
        "children": [
          {
            "text": "1Ô∏è‚É£ Infarto\\Nsubcortical reciente",
            "children": [
              {
                "text": "‚Æï Definici√≥n",
                "children": [
                  {
                    "text": "‚úîÔ∏è Lesi√≥n <20 mm en territorio de arteriola perforante",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Formaci√≥n en √∫ltimas semanas",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï RM Caracter√≠sticas",
                "children": [
                  {
                    "text": "‚úîÔ∏è Mejor visualizaci√≥n en DWI",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è ‚Üë Se√±al en T2 y FLAIR",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è ‚Üì Se√±al en T1",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "2Ô∏è‚É£ Lacuna de\\Norigen vascular",
            "children": [
              {
                "text": "‚Æï Definici√≥n",
                "children": [
                  {
                    "text": "‚úîÔ∏è Cavidad subcortical, rellena de l√≠quido",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Tama√±o: 3-15 mm",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Secuela de infarto subcortical o hemorragia previa",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï RM Caracter√≠sticas",
                "children": [
                  {
                    "text": "‚úîÔ∏è ‚Üì Se√±al en FLAIR y T2",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è ‚Üì o iso-se√±al en DWI",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Iso o ‚Üì se√±al en GRE",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "3Ô∏è‚É£ Hiperintensidades\\Nde sustancia blanca",
            "children": [
              {
                "text": "‚Æï Definici√≥n",
                "children": [
                  {
                    "text": "‚úîÔ∏è Anomal√≠as en sustancia blanca",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Excluye sustancia gris subcortical y tronco encef√°lico",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï RM Caracter√≠sticas",
                "children": [
                  {
                    "text": "‚úîÔ∏è ‚Üë Se√±al en FLAIR, T2 y GRE",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Iso-se√±al en DWI",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è ‚Üì o iso-se√±al en T1",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "4Ô∏è‚É£ Espacios perivasculares\\Nensanchados",
            "children": [
              {
                "text": "‚Æï Definici√≥n",
                "children": [
                  {
                    "text": "‚úîÔ∏è Espacios rellenos de l√≠quido siguiendo trayecto vascular",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Aparecen lineales (paralelos al vaso) o ovalados/redondos (perpendiculares)",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï RM Caracter√≠sticas",
                "children": [
                  {
                    "text": "‚úîÔ∏è <3 mm",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Mismo se√±al que LCR en todas las secuencias",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "5Ô∏è‚É£ Microhemorragias\\Ncerebrales",
            "children": [
              {
                "text": "‚Æï Definici√≥n",
                "children": [
                  {
                    "text": "‚úîÔ∏è Lesiones peque√±as (2-5 mm, hasta 10 mm)",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Vac√≠os de se√±al con ‚Äúblooming‚Äù en T2*/SWI",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï RM Caracter√≠sticas",
                "children": [
                  {
                    "text": "‚úîÔ∏è ‚Üì Se√±al en GRE y SWI",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Iso-se√±al en T1, T2, FLAIR y DWI",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "ACV Isqu√©mico por Peque√±os Vasos\\N(Lacunar Stroke - CSVD)",
        "children": [
          {
            "text": "‚û§ Definici√≥n",
            "children": [
              {
                "text": "‚Æï Manifestaci√≥n cl√≠nica aguda m√°s frecuente de CSVD",
                "children": []
              },
              {
                "text": "‚Æï Representa 20-30% de los ACV isqu√©micos",
                "children": []
              }
            ]
          },
          {
            "text": "‚û§ Historia y\\NTerminolog√≠a",
            "children": [
              {
                "text": "‚Æï 1838: Am√©d√©e Dechambre ‚Üí Describe cavidades por reabsorci√≥n",
                "children": []
              },
              {
                "text": "‚Æï 1843: Maxime Durand-Fardel ‚Üí Cavidades en ganglios basales por reblandecimiento",
                "children": []
              },
              {
                "text": "‚Æï Pierre Marie & Jean Ferrand",
                "children": [
                  {
                    "text": "‚úîÔ∏è Infartos lacunares por ruptura u obliteraci√≥n de arterias perforantes",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Localizaci√≥n cl√°sica: Puente, c√°psula interna, t√°lamo, sustancia blanca",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï C. Miller Fisher",
                "children": [
                  {
                    "text": "‚úîÔ∏è Descripci√≥n de >20 s√≠ndromes lacunares",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è 5 cl√°sicos ‚Üí Enfermedad de peque√±os vasos",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "S√çNDROMES\\NLACUNARES CL√ÅSICOS",
            "children": [
              {
                "text": "‚û§ Paresia\\Nmotora pura",
                "children": [
                  {
                    "text": "‚Æï S√≠ntomas: Debilidad en cara, brazo y pierna de un lado",
                    "children": []
                  },
                  {
                    "text": "‚Æï Ubicaci√≥n: C√°psula interna (brazo posterior), base pontis, putamen, n√∫cleo caudado",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚û§ Infarto\\Nsensitivo puro",
                "children": [
                  {
                    "text": "‚Æï S√≠ntomas: Parestesias o anestesia en cara, brazo y pierna de un lado, con o sin d√©ficit motor",
                    "children": []
                  },
                  {
                    "text": "‚Æï Ubicaci√≥n: N√∫cleo posteroventral del t√°lamo",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚û§ Ataxia-hemiparesia",
                "children": [
                  {
                    "text": "‚Æï S√≠ntomas: Hemiparesia pura + dismetr√≠a cerebelosa en el mismo lado",
                    "children": []
                  },
                  {
                    "text": "‚Æï Ubicaci√≥n: Base del puente",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚û§ Disartria-mano\\Ntorpe",
                "children": [
                  {
                    "text": "‚Æï S√≠ntomas: Disartria + debilidad facial + disfagia + torpeza y debilidad leve en la mano",
                    "children": []
                  },
                  {
                    "text": "‚Æï Ubicaci√≥n: Puente (basis pontis) o rodilla de la c√°psula interna",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚û§ Infarto\\Nsensoriomotor",
                "children": [
                  {
                    "text": "‚Æï S√≠ntomas: Debilidad y parestesias en cara, brazo y pierna de un lado",
                    "children": []
                  },
                  {
                    "text": "‚Æï Ubicaci√≥n: T√°lamo y c√°psula interna",
                    "children": []
                  }
                ]
              },
              {
                "text": "üìå IMPORTANTE",
                "children": [
                  {
                    "text": "‚úîÔ∏è Origen vascular: Oclusi√≥n de arterias perforantes",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Infartos peque√±os (<15 mm), alta asociaci√≥n con hipertensi√≥n arterial",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Diagn√≥stico: RM o TAC con √©nfasis en c√°psula interna, t√°lamo y protuberancia",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Tratamiento: Control de HTA, anticoagulaci√≥n si indicado, prevenci√≥n secundaria",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "LOCALIZACI√ìN DE\\NINFARTOS LACUNARES",
            "children": [
              {
                "text": "üìå Frecuencia descendente",
                "children": [
                  {
                    "text": "1Ô∏è‚É£ Putamen",
                    "children": []
                  },
                  {
                    "text": "2Ô∏è‚É£ Caudado",
                    "children": []
                  },
                  {
                    "text": "3Ô∏è‚É£ T√°lamo",
                    "children": []
                  },
                  {
                    "text": "4Ô∏è‚É£ Puente",
                    "children": []
                  },
                  {
                    "text": "5Ô∏è‚É£ C√°psula interna",
                    "children": []
                  },
                  {
                    "text": "6Ô∏è‚É£ Sustancia blanca subcortical",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "CASO CL√çNICO\\N(Caso 6-1)",
            "children": [
              {
                "text": "üë© Paciente: Mujer 56 a√±os, diestra",
                "children": []
              },
              {
                "text": "üÜò S√≠ntomas: D√©ficit sensitivo-motor derecho s√∫bito",
                "children": []
              },
              {
                "text": "ü©∫ Factores de riesgo:",
                "children": [
                  {
                    "text": "‚úîÔ∏è HTA en embarazo",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è HTA no tratada",
                    "children": []
                  }
                ]
              },
              {
                "text": "üìä NIHSS = 7",
                "children": [
                  {
                    "text": "‚ûû Debilidad facial derecha (2)",
                    "children": []
                  },
                  {
                    "text": "‚ûû Hemianestesia cara, brazo y pierna derecha (2)",
                    "children": []
                  },
                  {
                    "text": "‚ûû Hemiparesia brazo y pierna derecha (3)",
                    "children": []
                  }
                ]
              },
              {
                "text": "üìâ Estudios:",
                "children": [
                  {
                    "text": "‚úîÔ∏è TAC cerebral ‚Üí Sin hemorragia",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è AngioTAC ‚Üí Sin oclusi√≥n de gran vaso",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Laboratorio:",
                    "children": [
                      {
                        "text": "ü©∏ LDL = 131 mg/dL",
                        "children": []
                      },
                      {
                        "text": "ü©∏ HbA1c = 5.8%",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚úîÔ∏è RM ‚Üí Infarto tal√°mico izquierdo (DWI, ADC, FLAIR)",
                    "children": []
                  }
                ]
              },
              {
                "text": "üíä Manejo:",
                "children": [
                  {
                    "text": "‚úîÔ∏è rtPA IV",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Aspirina + atorvastatina",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Control de PA",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Consejer√≠a sobre adherencia y prevenci√≥n secundaria",
                    "children": []
                  }
                ]
              },
              {
                "text": "üè° Alta: Terapia ambulatoria",
                "children": []
              },
              {
                "text": "üìå Comentario:",
                "children": [
                  {
                    "text": "‚úîÔ∏è S√≠ndrome lacunar sensitivo-motor t√≠pico",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è HTA cr√≥nica = Principal factor de riesgo",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Control de PA + adherencia = Claves en prevenci√≥n secundaria",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "FACTORES DE RIESGO PARA\\NINFARTO LACUNAR",
            "children": [
              {
                "text": "‚û§ Principales",
                "children": [
                  {
                    "text": "‚Æï Hipertensi√≥n üö® (Factor clave)",
                    "children": []
                  },
                  {
                    "text": "‚Æï Diabetes mellitus",
                    "children": []
                  },
                  {
                    "text": "‚Æï Tabaquismo",
                    "children": []
                  },
                  {
                    "text": "‚Æï Hiperlipidemia (posible contribuyente)",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚û§ Pron√≥stico",
                "children": [
                  {
                    "text": "‚Æï Mortalidad ‚¨áÔ∏è vs. otros tipos de ACV",
                    "children": []
                  },
                  {
                    "text": "‚Æï Riesgo de recurrencia: 4-11% anual",
                    "children": []
                  },
                  {
                    "text": "‚Æï Modificado por perfil de FR",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "CONTROL DE PRESI√ìN ARTERIAL\\N(PA) Y PREVENCI√ìN SECUNDARIA",
            "children": [
              {
                "text": "üìå Dilema cl√≠nico: Meta √≥ptima de PA en ACV lacunar no definida",
                "children": []
              },
              {
                "text": "üß™ Estudio SPS3 (Secondary Prevention\\Nof Small Subcortical Stroke)",
                "children": [
                  {
                    "text": "‚Æï Compar√≥ PA sist√≥lica <130 mmHg vs. <150 mmHg",
                    "children": []
                  },
                  {
                    "text": "‚Æï Resultados:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è No diferencias en ACV total, fatal o incapacitante",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Reducci√≥n significativa en hemorragia intracerebral con PA <130 mmHg",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "üßæ Gu√≠a AHA/ASA (Clase I, Nivel B-R):",
                "children": [
                  {
                    "text": "‚Æï Meta PA <130/80 mmHg en ACV isqu√©mico",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚û§ Problema real",
                "children": [
                  {
                    "text": "‚Æï >50% pacientes con ACV lacunar tienen PA no controlada (>140/90 mmHg) despu√©s de 3 meses",
                    "children": []
                  },
                  {
                    "text": "‚Æï Desigualdades raciales en control de PA",
                    "children": []
                  },
                  {
                    "text": "‚Æï PA no controlada ‚Üí ‚¨ÜÔ∏è Riesgo de recurrencia, deterioro cognitivo y demencia",
                    "children": []
                  },
                  {
                    "text": "‚Æï Se necesitan intervenciones urgentes",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "OTROS FACTORES DE RIESGO\\NY COMORBILIDADES",
            "children": [
              {
                "text": "‚û§ Diabetes mellitus &\\NS√≠ndrome metab√≥lico",
                "children": [
                  {
                    "text": "‚Æï ‚¨ÜÔ∏è Riesgo de recurrencia",
                    "children": []
                  },
                  {
                    "text": "‚Æï ‚¨ÜÔ∏è Riesgo de IAM & mortalidad en ACV lacunar",
                    "children": []
                  },
                  {
                    "text": "‚Æï No hay evidencia de tratamiento diferente en ACV lacunar",
                    "children": []
                  },
                  {
                    "text": "‚Æï üîé Monitoreo m√°s cercano puede ser necesario",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "Angiopat√≠a Amiloide\\NCerebral (CAA)",
        "children": [
          {
            "text": "‚û§ Definici√≥n",
            "children": [
              {
                "text": "‚Æï Hallazgo patol√≥gico com√∫n en cerebros envejecidos",
                "children": []
              },
              {
                "text": "‚Æï Dep√≥sito de Œ≤-amiloide en paredes vasculares cerebrales",
                "children": []
              },
              {
                "text": "‚Æï Asociada a hemorragias, episodios neurol√≥gicos transitorios (TFNEs) y deterioro cognitivo",
                "children": []
              },
              {
                "text": "‚Æï Diagn√≥stico confirmado solo por autopsia",
                "children": []
              }
            ]
          },
          {
            "text": "‚û§ Epidemiolog√≠a",
            "children": [
              {
                "text": "‚Æï 50-60% en ancianos con demencia",
                "children": []
              },
              {
                "text": "‚Æï 20-40% en ancianos sin demencia",
                "children": []
              }
            ]
          },
          {
            "text": "PRESENTACIONES\\NCL√çNICAS DE CAA",
            "children": [
              {
                "text": "1Ô∏è‚É£ Hemorragia intracerebral\\N(ICH) relacionada a CAA",
                "children": [
                  {
                    "text": "‚Æï Afecta l√≥bulos occipital > frontal > temporal > parietal",
                    "children": []
                  },
                  {
                    "text": "‚Æï Puede ser √∫nica o m√∫ltiples ICH simult√°neas",
                    "children": []
                  },
                  {
                    "text": "‚Æï Recurrencia:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è CAA: 7.4% anual",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è ICH no CAA: 1.1% anual",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Æï Predictores\\Nde recurrencia:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Microhemorragias cerebrales m√∫ltiples",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Siderosis cortical difusa",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Hemorragia subaracnoidea convexa",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "2Ô∏è‚É£ Episodios Neurol√≥gicos Focales Transitorios\\N(TFNEs o ‚ÄúAmyloid Spells‚Äù)",
                "children": [
                  {
                    "text": "‚Æï Pueden simular AIT o crisis epil√©pticas",
                    "children": []
                  },
                  {
                    "text": "‚Æï Duraci√≥n: <30 min",
                    "children": []
                  },
                  {
                    "text": "‚Æï Fen√≥menos positivos:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Parestesias transitorias (mano, boca, migratorias)",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Æï Fen√≥menos\\Nnegativos:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Debilidad focal",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Trastornos del lenguaje",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Æï Asociaci√≥n\\Ncon:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Hemorragia subaracnoidea convexa",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Siderosis cortical superficial",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Æï Riesgo elevado de ICH lobar y muerte",
                    "children": []
                  }
                ]
              },
              {
                "text": "3Ô∏è‚É£ Deterioro\\NCognitivo",
                "children": [
                  {
                    "text": "‚Æï Prevalencia, progresi√≥n y perfil poco descritos",
                    "children": []
                  },
                  {
                    "text": "‚Æï Independiente del ICH (puede precederlo)",
                    "children": []
                  },
                  {
                    "text": "‚Æï Perfil similar a\\Ndeterioro vascular",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Disfunci√≥n ejecutiva",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Velocidad de procesamiento alterada",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Memoria relativamente preservada",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "DIAGN√ìSTICO\\NDE CAA",
            "children": [
              {
                "text": "‚û§\\\\/ Boston Criteria 2.\\N0 (2022)\\\\/",
                "children": [
                  {
                    "text": "‚Æï Diagn√≥stico basado en cl√≠nica, neuroimagen e histopatolog√≠a",
                    "children": []
                  },
                  {
                    "text": "‚Æï ‚Üë Sensibilidad y especificidad",
                    "children": []
                  },
                  {
                    "text": "‚Æï Clasificaci√≥n:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Definitivo ‚Üí Postmortem",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Probable ‚Üí Caracter√≠sticas radiogr√°ficas y cl√≠nicas",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Posible ‚Üí Sin hallazgos concluyentes",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "‚û§ Hallazgos en RM (Figura 6-3 y 6-4)",
                "children": [
                  {
                    "text": "‚Æï Microhemorragias cerebrales (T2*/SWI)",
                    "children": []
                  },
                  {
                    "text": "‚Æï Siderosis cortical superficial",
                    "children": []
                  },
                  {
                    "text": "‚Æï Hemorragia lobar (convexidad subaracnoidea)",
                    "children": []
                  },
                  {
                    "text": "‚Æï Hiperintensidades de sustancia blanca",
                    "children": []
                  },
                  {
                    "text": "‚Æï Infartos silentes",
                    "children": []
                  },
                  {
                    "text": "‚Æï Espacios perivasculares visibles en centro semioval",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "ANGIOPAT√çA AMILOIDE CEREBRAL (CAA) -\\NCRITERIOS DIAGN√ìSTICOS",
            "children": [
              {
                "text": "1Ô∏è‚É£ CAA DEFINITIVA",
                "children": [
                  {
                    "text": "‚úîÔ∏è Examen post mortem de cerebro completo",
                    "children": []
                  },
                  {
                    "text": "‚Æï Hallazgos:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è ICH espont√°nea, TFNEs, cSAH o deterioro cognitivo/demencia",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è CAA severa con vasculopat√≠a",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Ausencia de otras lesiones diagn√≥sticas",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "2Ô∏è‚É£ CAA PROBABLE CON\\NAPOYO PATOL√ìGICO",
                "children": [
                  {
                    "text": "‚úîÔ∏è Datos cl√≠nicos + hallazgos patol√≥gicos en biopsia (hematoma evacuado o corteza cerebral)",
                    "children": []
                  },
                  {
                    "text": "‚Æï Presentaci√≥n cl√≠nica:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è ICH espont√°nea, TFNEs, cSAH o deterioro cognitivo/demencia",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Æï Histolog√≠a:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Presencia de CAA en la muestra",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Ausencia de otras lesiones diagn√≥sticas",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "3Ô∏è‚É£ CAA PROBABLE (CRITERIOS\\NCL√çNICOS Y DE IMAGEN)",
                "children": [
                  {
                    "text": "‚úîÔ∏è Pacientes ‚â•50 a√±os",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Presentaci√≥n cl√≠nica:",
                    "children": [
                      {
                        "text": "‚Æï ICH espont√°nea, TFNEs, cSAH o deterioro cognitivo/demencia",
                        "children": [
                          {
                            "text": "‚úîÔ∏è Hallazgos en imagen (RM T2 o SWI)*",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "‚Æï Opci√≥n 1:",
                        "children": [
                          {
                            "text": "‚úîÔ∏è ‚â•2 lesiones hemorr√°gicas lobares estrictamente corticales",
                            "children": []
                          },
                          {
                            "text": "‚úîÔ∏è En cualquier combinaci√≥n: ICH, microhemorragias, cSAH",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "‚Æï Opci√≥n 2:",
                        "children": [
                          {
                            "text": "‚úîÔ∏è 1 hemorragia lobar + 1 hallazgo en sustancia blanca",
                            "children": []
                          },
                          {
                            "text": "‚úîÔ∏è Perivascular spaces aumentados en centrum semiovale o hiperintensidad en sustancia blanca con patr√≥n multi-foco",
                            "children": []
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "‚úîÔ∏è Ausencia de:",
                    "children": [
                      {
                        "text": "‚Æï Lesiones hemorr√°gicas profundas (ICH o microhemorragias)",
                        "children": []
                      },
                      {
                        "text": "‚Æï Otras causas de hemorragia",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚úîÔ∏è Lesi√≥n hemorr√°gica en cerebelo no cuenta como criterio",
                    "children": []
                  }
                ]
              },
              {
                "text": "4Ô∏è‚É£ CAA POSIBLE",
                "children": [
                  {
                    "text": "‚úîÔ∏è Pacientes ‚â•50 a√±os",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Presentaci√≥n cl√≠nica:",
                    "children": [
                      {
                        "text": "‚Æï ICH espont√°nea, TFNEs, cSAH o\\Ndeterioro cognitivo/demencia",
                        "children": [
                          {
                            "text": "‚úîÔ∏è Ausencia de otras causas de hemorragia",
                            "children": []
                          },
                          {
                            "text": "‚úîÔ∏è Hallazgos en imagen (RM T2 o SWI)*",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "‚Æï Opci√≥n 1:",
                        "children": [
                          {
                            "text": "‚úîÔ∏è 1 √∫nica hemorragia lobar estrictamente cortical",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "‚Æï Opci√≥n 2:",
                        "children": [
                          {
                            "text": "‚úîÔ∏è Alteraciones en sustancia blanca (perivascular spaces en centrum semiovale o hiperintensidades en patr√≥n multi-foco)",
                            "children": []
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "‚úîÔ∏è Ausencia de:",
                    "children": [
                      {
                        "text": "‚Æï Lesiones hemorr√°gicas profundas (ICH o microhemorragias)",
                        "children": []
                      },
                      {
                        "text": "‚Æï Otras causas de hemorragia",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚úîÔ∏è Lesi√≥n hemorr√°gica en cerebelo no cuenta como criterio",
                    "children": []
                  }
                ]
              },
              {
                "text": "üìå IMPORTANTE",
                "children": [
                  {
                    "text": "‚úîÔ∏è ICH = Hemorragia Intracerebral",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è TFNEs = Episodios neurol√≥gicos focales transitorios",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è cSAH = Hemorragia subaracnoidea convexa focal",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è RM T2/SWI fundamentales para el diagn√≥stico*",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Excluir otras causas de hemorragia antes de confirmar CAA",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "EPISODIOS NEUROL√ìGICOS FOCALES TRANSITORIOS (TFNE)\\NRELACIONADOS CON CAA",
            "children": [
              {
                "text": "1Ô∏è‚É£ Caracter√≠sticas\\Nesenciales",
                "children": [
                  {
                    "text": "‚úîÔ∏è S√≠ntomas transitorios\\N(motor, sensorial o ambos)",
                    "children": [
                      {
                        "text": "‚Æï Puede incluir disartria o afasia",
                        "children": []
                      },
                      {
                        "text": "‚Æï Resoluci√≥n ‚â§30 min (casi siempre ‚â§3 h)",
                        "children": []
                      },
                      {
                        "text": "‚Æï Diseminaci√≥n progresiva entre √°reas contiguas de la corteza",
                        "children": []
                      },
                      {
                        "text": "‚Æï Patr√≥n recurrente estereotipado en d√≠as o semanas",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚úîÔ∏è Evidencia neuropatol√≥gica o de neuroimagen de CAA probable o posible\\N(seg√∫n Criterios de Boston)",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Edad ‚â•55 a√±os",
                    "children": []
                  }
                ]
              },
              {
                "text": "2Ô∏è‚É£ Criterios de apoyo ‚Üí Sugiere\\NTFNE relacionado con CAA",
                "children": [
                  {
                    "text": "‚úîÔ∏è Presencia de hemorragia subaracnoidea convexa aguda",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Presencia de siderosis superficial cortical en un surco adyacente al giro sintom√°tico",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Sin otra causa identificada",
                    "children": []
                  }
                ]
              },
              {
                "text": "3Ô∏è‚É£ Criterios de exclusi√≥n ‚Üí No es un\\NTFNE relacionado con CAA",
                "children": [
                  {
                    "text": "‚úîÔ∏è Infarto agudo con patr√≥n emb√≥lico t√≠pico (‚â† CAA)",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Pacientes con TFNE por CAA pueden tener lesiones peque√±as en DWI",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Si hay evidencia de tromboembolismo, NO es TFNE por CAA",
                    "children": []
                  }
                ]
              },
              {
                "text": "4Ô∏è‚É£ Criterios de incertidumbre\\N‚Üí Diagn√≥stico dudoso",
                "children": [
                  {
                    "text": "‚úîÔ∏è Explicaciones alternativas posibles",
                    "children": [
                      {
                        "text": "‚Æï FA u otras causas de eventos transitorios",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚úîÔ∏è Falta de caracter√≠sticas de apoyo para TFNE por CAA",
                    "children": []
                  }
                ]
              },
              {
                "text": "üìå IMPORTANTE",
                "children": [
                  {
                    "text": "‚úîÔ∏è TFNE en CAA ‚â† AIT emb√≥lico ‚Üí Diferencia clave",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Sospecha alta en adultos ‚â•55 a√±os con CAA documentada",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Neuroimagen clave (SWI, FLAIR, T2) para siderosis o cSAH*",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "MANEJO Y\\NPREVENCI√ìN",
            "children": [
              {
                "text": "1Ô∏è‚É£ Control de PA",
                "children": [
                  {
                    "text": "üìå AHA/ASA:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Meta PA <130/80 mmHg (Clase 2a)",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Reducci√≥n PA recomendada en ICH espont√°neo (Clase 1)",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "2Ô∏è‚É£ Antitromb√≥ticos y\\NAnticoagulaci√≥n",
                "children": [
                  {
                    "text": "‚ùå Aspirina & Warfarina ‚Üí Asociadas a ‚Üë riesgo hemorr√°gico",
                    "children": []
                  },
                  {
                    "text": "üß™ Estudios en curso:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è ASPIRE ‚Üí Anticoagulaci√≥n vs. Aspirina en ICH por CAA",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è ENRICH-AF ‚Üí Edoxaban en FA con ICH por CAA",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "üìå AHA/ASA (Clase 2b):",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Oclusi√≥n de orejuela auricular izquierda puede considerarse en FA con CAA",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Reinicio de anticoagulaci√≥n ‚Üí Decisi√≥n individualizada",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "CADASIL (Arteriopat√≠a Cerebral\\NAutos√≥mica Dominante con Infartos\\NSubcorticales y Leucoencefalopat√≠a)",
        "children": [
          {
            "text": "‚û§ Definici√≥n",
            "children": [
              {
                "text": "‚Æï Enfermedad monog√©nica de peque√±os vasos m√°s com√∫n",
                "children": []
              },
              {
                "text": "‚Æï Causada por mutaciones en NOTCH3 (cromosoma 19p)",
                "children": []
              },
              {
                "text": "‚Æï Prevalencia: 2-5 por 100,000",
                "children": []
              },
              {
                "text": "‚Æï Herencia autos√≥mica dominante",
                "children": []
              }
            ]
          },
          {
            "text": "MANIFESTACIONES\\NCL√çNICAS",
            "children": [
              {
                "text": "‚û§ S√≠ntomas\\Nprincipales",
                "children": [
                  {
                    "text": "‚Æï Migra√±a con aura (frecuente, 3¬∞ d√©cada)",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Puede presentarse como migra√±a sin aura o aura aislada",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Æï Eventos isqu√©micos\\Nsubcorticales",
                    "children": [
                      {
                        "text": "‚úîÔ∏è ACV isqu√©mico lacunar",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Ataques isqu√©micos transitorios (AIT)",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Presentaci√≥n en 5¬∞ d√©cada",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Æï Episodios confusionales\\Nagudos (10%)",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Evolucionan desde crisis migra√±osas",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è S√≠ntomas: Confusi√≥n, ‚Üì conciencia, crisis epil√©pticas, alucinaciones, debilidad focal",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Æï Trastornos psiqui√°tricos\\N(20-40%)",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Apat√≠a",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Depresi√≥n mayor",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Afecto pseudobulbar",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Trastorno bipolar",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Æï Deterioro cognitivo\\Nprogresivo",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Afectaci√≥n de funci√≥n ejecutiva y velocidad de procesamiento",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Memoria relativamente preservada en etapas iniciales",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "CASO CL√çNICO\\N(Caso 6-3)",
            "children": [
              {
                "text": "üë© Paciente: Mujer 48 a√±os, diestra",
                "children": []
              },
              {
                "text": "üÜò S√≠ntomas: Debilidad aguda en hemicuerpo izquierdo",
                "children": []
              },
              {
                "text": "ü©∫ Antecedentes:",
                "children": [
                  {
                    "text": "‚úîÔ∏è Migra√±a con aura desde los 20 a√±os",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Madre con m√∫ltiples ACV y demencia",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è T√≠a materna con depresi√≥n mayor y AITs recurrentes",
                    "children": []
                  }
                ]
              },
              {
                "text": "üìâ Estudios:",
                "children": [
                  {
                    "text": "‚úîÔ∏è TAC cerebral & AngioTAC ‚Üí Normales",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è RM cerebral ‚Üí Infarto tal√°mico derecho + Hiperintensidades extensas de sustancia blanca",
                    "children": []
                  },
                  {
                    "text": "üß¨ Gen√©tica: Mutaci√≥n en NOTCH3 ‚Üí Diagn√≥stico de CADASIL",
                    "children": []
                  }
                ]
              },
              {
                "text": "üìå Comentario:",
                "children": [
                  {
                    "text": "‚úîÔ∏è Historia cl√≠nica y hallazgos radiogr√°ficos cl√°sicos de CADASIL",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "FISIOPATOLOG√çA",
            "children": [
              {
                "text": "‚û§ Gen√©tica",
                "children": [
                  {
                    "text": "‚Æï Mutaci√≥n en NOTCH3 (19p)",
                    "children": []
                  },
                  {
                    "text": "‚Æï Afecta c√©lulas musculares lisas vasculares y pericitos",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚û§ Cambios\\Nhistol√≥gicos",
                "children": [
                  {
                    "text": "‚Æï Engrosamiento de la pared vascular + estenosis luminal",
                    "children": []
                  },
                  {
                    "text": "‚Æï Degeneraci√≥n de c√©lulas musculares lisas",
                    "children": []
                  },
                  {
                    "text": "‚Æï Dep√≥sitos granulares osmioph√≠licos (NOTCH3) en t√∫nica media",
                    "children": []
                  },
                  {
                    "text": "‚Æï Acumulaci√≥n de col√°geno, laminina y matriz fibrosa en t√∫nica adventicia",
                    "children": []
                  }
                ]
              },
              {
                "text": "üìå Mecanismo exacto de infarto en CADASIL a√∫n desconocido",
                "children": []
              }
            ]
          },
          {
            "text": "HALLAZGOS EN\\NNEUROIMAGEN",
            "children": [
              {
                "text": "‚û§ RM cerebral\\N(Figura 6-5)",
                "children": [
                  {
                    "text": "‚Æï Hiperintensidades en sustancia blanca subcortical",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Involucra c√°psula externa y polos temporales",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Æï Infartos lacunares (cl√≠nicos y silentes)",
                    "children": []
                  },
                  {
                    "text": "‚Æï Microhemorragias cerebrales (50% de los casos)",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "DIAGN√ìSTICO",
            "children": [
              {
                "text": "üìå Sospecha\\Nen presencia de:",
                "children": [
                  {
                    "text": "‚úîÔ∏è Cl√≠nica caracter√≠stica",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Antecedente familiar (puede haber presentaci√≥n espor√°dica)",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Hallazgos radiogr√°ficos t√≠picos",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚û§ Confirmaci√≥n\\Ndiagn√≥stica",
                "children": [
                  {
                    "text": "üß¨ Gen√©tica: Mutaci√≥n en NOTCH3",
                    "children": []
                  },
                  {
                    "text": "üî¨ Biopsia de piel (alternativa cuando gen√©tica no disponible)",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Dep√≥sitos granulares osmioph√≠licos en peque√±os vasos",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "üìå Ausencia de antecedentes familiares NO descarta CADASIL",
                "children": []
              }
            ]
          },
          {
            "text": "DIAGN√ìSTICO\\NDIFERENCIAL",
            "children": [
              {
                "text": "‚û§ CARASIL (Arteriopat√≠a Cerebral\\NAutos√≥mica Recesiva con Infartos\\NSubcorticales y Leucoencefalopat√≠a)",
                "children": [
                  {
                    "text": "‚Æï Diferencias clave\\Ncon CADASIL:",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Herencia recesiva",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Spondilosis deformante",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Alopecia precoz",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Mutaci√≥n en HTRA1",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "MANEJO Y\\NPREVENCI√ìN",
            "children": [
              {
                "text": "1Ô∏è‚É£ Control de Factores\\Nde Riesgo Vascular",
                "children": [
                  {
                    "text": "üìå HTA y tabaquismo\\Nempeoran el pron√≥stico",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Control estricto de PA",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Evitar tabaco",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "2Ô∏è‚É£ Tratamiento Antitromb√≥tico",
                "children": [
                  {
                    "text": "ü©∏ Antiagregantes plaquetarios (Aspirina/Clopidogrel):",
                    "children": [
                      {
                        "text": "‚úîÔ∏è Uso frecuente, pero beneficio incierto en CADASIL",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "ü©∏ Anticoagulaci√≥n:",
                    "children": [
                      {
                        "text": "‚ùå Riesgo de hemorragia (microhemorragias comunes en CADASIL)",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "üìå Decisi√≥n individualizada",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "CONCLUSI√ìN",
            "children": [
              {
                "text": "‚û§ CSVD: Condici√≥n cl√≠nica frecuente\\N(siglos de reconocimiento)",
                "children": [
                  {
                    "text": "‚Æï Hallazgos radiogr√°ficos claros en diferentes subtipos",
                    "children": []
                  },
                  {
                    "text": "‚Æï Contribuye a morbilidad\\Ny mortalidad global",
                    "children": [
                      {
                        "text": "‚úîÔ∏è ACV",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Deterioro cognitivo",
                        "children": []
                      },
                      {
                        "text": "‚úîÔ∏è Demencia",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Æï Faltan conocimientos sobre fisiopatolog√≠a y terapias espec√≠ficas",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚û§ Hipertensi√≥n (HTA):\\NPrincipal factor de riesgo",
                "children": [
                  {
                    "text": "‚Æï HTA no controlada ‚Üí ‚¨ÜÔ∏è Riesgo de CSVD y ACV recurrente",
                    "children": []
                  },
                  {
                    "text": "‚Æï Control de PA sigue siendo sub√≥ptimo",
                    "children": []
                  },
                  {
                    "text": "‚Æï Fisher (1965): ‚ÄúEl control de la HTA es clave en la prevenci√≥n de ACV lacunares‚Äù",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚û§ Futuro",
                "children": [
                  {
                    "text": "‚Æï Estrategias terap√©uticas basadas en fisiopatolog√≠a",
                    "children": []
                  },
                  {
                    "text": "‚Æï Intervenciones urgentes en control de PA",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "PUNTOS CLAVES",
        "children": [
          {
            "text": "‚û§ Impacto de CSVD",
            "children": [
              {
                "text": "‚Æï Contribuye a ACV, deterioro cognitivo y demencia",
                "children": []
              }
            ]
          },
          {
            "text": "‚û§ Factores de Riesgo Modificables",
            "children": [
              {
                "text": "‚Æï HTA, apnea del sue√±o, diabetes, dislipidemia y tabaquismo",
                "children": []
              }
            ]
          },
          {
            "text": "‚û§ CSVD: Trastorno\\Ndin√°mico global",
            "children": [
              {
                "text": "‚Æï Disfunci√≥n endotelial + Alteraciones en unidad neurovascular",
                "children": []
              },
              {
                "text": "‚Æï Mejor entendimiento = Posibles dianas terap√©uticas",
                "children": []
              },
              {
                "text": "‚û§ 6 Fenotipos\\NRadiogr√°ficos de CSVD",
                "children": [
                  {
                    "text": "1Ô∏è‚É£ Infarto subcortical reciente",
                    "children": []
                  },
                  {
                    "text": "2Ô∏è‚É£ Hiperintensidades de sustancia blanca",
                    "children": []
                  },
                  {
                    "text": "3Ô∏è‚É£ Lacuna de origen vascular",
                    "children": []
                  },
                  {
                    "text": "4Ô∏è‚É£ Espacios perivasculares ensanchados",
                    "children": []
                  },
                  {
                    "text": "5Ô∏è‚É£ Microhemorragias cerebrales",
                    "children": []
                  },
                  {
                    "text": "6Ô∏è‚É£ Atrofia cerebral",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "‚û§ Infarto Lacunar\\N(CSVD Isqu√©mico)",
            "children": [
              {
                "text": "‚Æï Manifestaci√≥n cl√≠nica aguda m√°s com√∫n",
                "children": []
              },
              {
                "text": "‚Æï 20-30% de ACV isqu√©micos",
                "children": []
              },
              {
                "text": "‚Æï Factores de riesgo: HTA, diabetes, tabaquismo, dislipidemia",
                "children": []
              }
            ]
          },
          {
            "text": "‚û§ Control de\\NPA en CSVD",
            "children": [
              {
                "text": "üìå AHA/ASA: Meta PA <130/80 mmHg en ACV isqu√©mico (Clase 1, Nivel B-R)",
                "children": []
              },
              {
                "text": "üìå HTA no controlada ‚Üí ‚¨ÜÔ∏è Riesgo de recurrencia, deterioro cognitivo y demencia",
                "children": []
              },
              {
                "text": "üìå Intervenciones urgentes necesarias",
                "children": []
              }
            ]
          },
          {
            "text": "‚û§ Angiopat√≠a Amiloide\\NCerebral (CAA)",
            "children": [
              {
                "text": "‚Æï Diagn√≥stico con Boston Criteria 2.0",
                "children": []
              },
              {
                "text": "‚Æï Hallazgos en RM:",
                "children": [
                  {
                    "text": "‚úîÔ∏è Hemorragia cortical",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Microhemorragias cerebrales",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Siderosis cortical",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è HSA convexal",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Infartos silentes",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Hiperintensidades de sustancia blanca",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Espacios perivasculares en centro semioval",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï Recurrencia de ICH en CAA: 7.4% anual vs. 1.1% en ICH no CAA",
                "children": []
              },
              {
                "text": "‚Æï Episodios neurol√≥gicos\\Nfocales transitorios (TFNEs)",
                "children": [
                  {
                    "text": "‚úîÔ∏è Duraci√≥n <30 min",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è D√©ficits motores, sensitivos, lenguaje o visuales",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è Dificultad para diferenciar de AIT o crisis epil√©ptica",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Æï Perfil cognitivo similar a deterioro vascular (Ejecutivo > memoria)",
                "children": []
              },
              {
                "text": "‚Æï Manejo:",
                "children": [
                  {
                    "text": "‚úîÔ∏è PA <130/80 mmHg (Clase 2a)",
                    "children": []
                  },
                  {
                    "text": "‚úîÔ∏è No gu√≠as espec√≠ficas para prevenci√≥n de ICH",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "‚û§ CADASIL (Enfermedad Monog√©nica de\\NPeque√±os Vasos m√°s Com√∫n)",
            "children": [
              {
                "text": "‚Æï Primera manifestaci√≥n: Migra√±a con aura (3¬∞ d√©cada)",
                "children": []
              },
              {
                "text": "‚Æï Eventos isqu√©micos subcorticales (ACV/AIT) en 5¬∞ d√©cada",
                "children": []
              },
              {
                "text": "‚Æï Episodios confusionales, depresi√≥n y deterioro cognitivo progresivo",
                "children": []
              },
              {
                "text": "‚Æï RM: Hiperintensidades subcorticales (c√°psula externa y polos temporales)",
                "children": []
              },
              {
                "text": "‚Æï Diagn√≥stico: Mutaci√≥n NOTCH3 (19p)",
                "children": []
              },
              {
                "text": "‚Æï Manejo: Control de FR vascular (HTA, tabaquismo)",
                "children": []
              }
            ]
          },
          {
            "text": "‚û§ CARASIL (Diferencial\\Ncon CADASIL)",
            "children": [
              {
                "text": "‚Æï Autos√≥mico recesivo (HTRA1)",
                "children": []
              },
              {
                "text": "‚Æï\\\\/ Spondilosis deformante + Alopecia precoz\\\\/",
                "children": []
              }
            ]
          }
        ]
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1633",
      "title": "ACV: ESCALAS DE UTILIDAD CL√çNICA"
    },
    {
      "id": "map_1673",
      "title": "DAPA-CKD (2020)\\NDapagliflozin And Prevention\\Nof Adverse outcomes in CKD\\N\\N‚≠ê iSGLT2 protege ri√±√≥n\\NINCLUSO SIN DIABETES\\N(Extiende beneficio a ERC no-DM)"
    },
    {
      "id": "map_1674",
      "title": "CREDENCE (2019)\\NCanagliflozin and Renal Events in Diabetes\\N\\nCanagliflozina reduce progresion ERC\\ny eventos CV en DM2 con nefropatia\\nNNTH 22 para outcome renal"
    },
    {
      "id": "map_1107",
      "title": "Deterioro Cognitivo Vascular (DCV) y Demencia Vascular"
    },
    {
      "id": "map_1054",
      "title": "Evaluaci√≥n de la Demencia y el Deterioro Cognitivo  UTD 2025"
    }
  ],
  "source_file": "Continiuum. Enfermedad de PequenÃÉos Vasos Cerebrales (CSVD)-2025.smmx",
  "created": "2026-02-07T15:42:53.258033"
}